Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling. - Wikidata - awgldk - TriplyDB

Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling.

Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling.

http://www.wikidata.org/entity/Q35021035

about

Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease miR-30a Regulates the Expression of CAGE and p53 and Regulates the Response to Anti-Cancer Drugs miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2.A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ.Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases.ECM1 regulates tumor metastasis and CSC-like property through stabilization of β-catenin.The Diacetyl-Exposed Human Airway Epithelial Secretome: New Insights into Flavoring-Induced Airways Disease.Controlling Directed Protein Interaction Networks in Cancer.Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer.A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.Multiplexed panel of precisely quantified salivary proteins for biomarker assessment.Regulation of Tumor Progression by Programmed Necrosis.

P2860

Q28550766-3FA2A0D3-27AB-466D-8460-61D6C17B3020 Q28739536-BC8765E7-1FD9-4C71-9DB3-32844AAC42DF Q36835365-6883156C-CD7B-4521-8584-E049E72CFEF9 Q36962950-804CE36C-5855-48F3-A0C2-E7D4C17F2209 Q37724883-E8443541-9EBF-4A9A-AED7-0480883AE407 Q38738904-8798D68B-80DA-4AD4-BC33-D45BA062F5A9 Q38902925-7EBC74A7-41CE-4793-9891-E89DA74F296C Q38935891-53FC3615-E0DE-4631-BEED-D75A58178E85 Q41605713-D114AA84-4BDE-49FA-A547-F8FC41AD9F3B Q47616522-34CFB0A8-00A8-4DCD-A6D9-30A493E5C6D5 Q48134448-161E1502-C1E1-4649-8655-267CAA566405 Q51564069-15E33AFE-3A5E-405B-9F9D-E1FF23ACBD11 Q52720171-985EDD69-2292-4915-83C6-C32CC71422A6

P2860

Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling.

http://www.wikidata.org/entity/Q35021035

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Extracellular matrix protein 1 ...... ermal growth factor signaling.

@ast

Extracellular matrix protein 1 ...... ermal growth factor signaling.

@en

type

label

Extracellular matrix protein 1 ...... ermal growth factor signaling.

@ast

Extracellular matrix protein 1 ...... ermal growth factor signaling.

@en

prefLabel

Extracellular matrix protein 1 ...... ermal growth factor signaling.

@ast

Extracellular matrix protein 1 ...... ermal growth factor signaling.

@en

P1433

Q35021035-28880420-F399-470F-83AD-1B6E008EE838

P1476

Q35021035-2DC93A1B-3260-456A-97E1-DD9D91C5145C

P2093

Q35021035-0B1A379A-7BBB-45D9-9532-581E440F57E4

Q35021035-0CDE995E-C111-4A89-BD18-57DBC32B1EDA

Q35021035-118886BD-F865-4401-8CF5-59EA9C0AA87A

Q35021035-129FE6FF-C59E-44F9-9095-555143817148

Q35021035-3087C330-C193-4060-ADC7-DA39D07543B1

Q35021035-544B376C-20E9-4E1D-B43A-CD99B802250F

Q35021035-CE7C475C-A170-444D-BB76-361205AD0EFF

Q35021035-D0DFFABE-9051-4266-8E93-414CF7E5C16A

Q35021035-DCA740DD-BB85-4FF7-BFD1-9EE305407F2F

Q35021035-DD4C0F5E-8AB3-41BA-A62D-AB1A04FEA290

P2860

Q35021035-031D05FF-6D36-4B52-8382-084E65D36059

Q35021035-04E0E208-C49A-4468-858E-265E03B9F06F

Q35021035-0CBA2206-CA8A-495F-B833-79660E544FF8

Q35021035-14046DA4-8E86-4B52-BA78-4F7E3EC34775

Q35021035-1DE8885A-0243-43D0-89D4-D6101CF9E5C5

Q35021035-2541DF60-262C-46FC-A99D-C0D344256BEB

Q35021035-262F87DE-E966-4846-B70F-DDBF08A24FE9

Q35021035-2888D96F-9D25-48B1-896F-145F87E5C295

Q35021035-2ADF1979-2D21-4EA3-88B7-A17B27761EB7

Q35021035-35279913-8F28-4571-BDE7-75C5E18DB731

P2888

Q35021035-47EA7226-FE42-4406-A0AB-206476B9A522

P304

Q35021035-D8B9E7E0-A2C7-4533-AE62-56F82B3915F7

P31

Q35021035-5AA2743E-F7BD-41A5-80EC-4DC65862F1C0

P356

Q35021035-C10232AB-3BCD-4A49-9F62-147E235A29BD

P433

Q35021035-F45F2BDF-D58A-4DC3-9EFB-FE93B7D01F9E

P478

Q35021035-BE666BE2-4259-4C3E-8515-23C8DEFC9D3F

P50

Q35021035-DE5E33DF-B899-44D1-8AB4-69A85D18F5A3

P577

Q35021035-900EC49D-1C50-4FE3-8727-E8262377AE22

P5875

Q35021035-21FFC786-BF56-4AA1-98F3-71F44A959A86

P6179

Q35021035-5778BB1A-14AC-4E71-9067-CC13DCC7F75F

P698

Q35021035-0AE097BE-9993-4153-9A6F-66679E1B0706

P921

Q35021035-9D5EDC1C-57BE-4C6B-8C54-E3E4CFFFB8C8

P932

Q35021035-B4A8DC2C-E640-4E5A-814B-AA05F002B0D2

P356

S13058-014-0479-6

P1433

Breast Cancer Research

P1476

Extracellular matrix protein 1 ...... ermal growth factor signaling.

@en

P2093

Incheol Shin

http://www.w3.org/2001/XMLSchema#string

Jong Won Lee

http://www.w3.org/2001/XMLSchema#string

Jong-Han Yu

http://www.w3.org/2001/XMLSchema#string

Juyeon Lim

http://www.w3.org/2001/XMLSchema#string

Keesoo Nam

http://www.w3.org/2001/XMLSchema#string

Kyung-min Lee

http://www.w3.org/2001/XMLSchema#string

Sei-Hyun Ahn

http://www.w3.org/2001/XMLSchema#string

Sung-Bae Kim

http://www.w3.org/2001/XMLSchema#string

Sunhwa Oh

http://www.w3.org/2001/XMLSchema#string

Taehoon Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells

Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis

Extracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high-affinity protein/protein interactions

Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells

Humanization of an anti-p185HER2 antibody for human cancer therapy

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland

Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface

P2888

s13058-014-0479-6

P304

479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13058-014-0479-6

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269718481

http://www.w3.org/2001/XMLSchema#string

P6179

1051692484

http://www.w3.org/2001/XMLSchema#string

P698

25499743

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

P932

4308848

http://www.w3.org/2001/XMLSchema#string